BIOMAT Database Logo BIOMAT Database Logo

Pathogen-Boosted Adoptive Cell Transfer Therapy Induces Endogenous Antitumor Immunity through Antigen Spreading. 2020

Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
Blood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin.

Loss of target antigens in tumor cells has become one of the major hurdles limiting the efficacy of adoptive cell therapy (ACT)-based immunotherapies. The optimal approach to overcome this challenge includes broadening the immune response from the initially targeted tumor-associated antigen (TAA) to other TAAs expressed in the tumor. To induce a more broadly targeted antitumor response, we utilized our previously developed Re-energized ACT (ReACT), which capitalizes on the synergistic effect of pathogen-based immunotherapy and ACT. In this study, we showed that ReACT induced a sufficient endogenous CD8+ T-cell response beyond the initial target to prevent the outgrowth of antigen loss variants in a B16-F10 melanoma model. Sequentially, selective depletion experiments revealed that Batf3-driven cDC1s were essential for the activation of endogenous tumor-specific CD8+ T cells. In ReACT-treated mice that eradicated tumors, we observed that endogenous CD8+ T cells differentiated into memory cells and facilitated the rejection of local and distal tumor rechallenge. By targeting one TAA with ReACT, we provided broader TAA coverage to counter antigen escape and generate a durable memory response against local relapse and metastasis.See related Spotlight on p. 2.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D008088 Listeriosis Infections with bacteria of the genus LISTERIA. Listeria Infections,Infections, Listeria,Infection, Listeria,Listeria Infection,Listerioses
D008089 Listeria monocytogenes A species of gram-positive, rod-shaped bacteria widely distributed in nature. It has been isolated from sewage, soil, silage, and from feces of healthy animals and man. Infection with this bacterium leads to encephalitis, meningitis, endocarditis, and abortion.
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D016219 Immunotherapy, Adoptive Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314) Adoptive Cellular Immunotherapy,Adoptive Immunotherapy,CAR T-Cell Therapy,Cellular Immunotherapy, Adoptive,Chimeric Antigen Receptor Therapy,Immunotherapy, Adoptive Cellular,Adoptive Cellular Immunotherapies,Adoptive Immunotherapies,CAR T Cell Therapy,CAR T-Cell Therapies,Cellular Immunotherapies, Adoptive,Immunotherapies, Adoptive,Immunotherapies, Adoptive Cellular,T-Cell Therapies, CAR,T-Cell Therapy, CAR,Therapies, CAR T-Cell,Therapy, CAR T-Cell

Related Publications

Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
Pathogen boosted adoptive cell transfer immunotherapy to treat solid tumors.
January 2017, Proceedings of the National Academy of Sciences of the United States of America,
Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
Vaccine-Boosted CAR T-cell Therapy Elicits Antigen Spreading.
September 2023, Cancer discovery,
Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity.
August 2020, Nature immunology,
Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
Adoptive transfer of T-cell immunity.
May 2002, Trends in immunology,
Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
Two is better than one: advances in pathogen-boosted immunotherapy and adoptive T-cell therapy.
September 2017, Immunotherapy,
Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
Antitumor immunity induced by laser immunotherapy and its adoptive transfer.
January 2001, Cancer research,
Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
Recent advances in biomaterial-boosted adoptive cell therapy.
March 2022, Chemical Society reviews,
Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
Adoptive cell transfer therapy.
December 2007, Seminars in oncology,
Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
Engineering antitumor immunity by T-cell adoptive immunotherapy.
January 2007, Hematology. American Society of Hematology. Education Program,
Gang Xin, and Achia Khatun, and Paytsar Topchyan, and Ryan Zander, and Peter J Volberding, and Yao Chen, and Jian Shen, and Chunmei Fu, and Aimin Jiang, and William A See, and Weiguo Cui
The power of combining adoptive cell therapy (ACT) and pathogen-boosted vaccination to treat solid tumors.
October 2017, Human vaccines & immunotherapeutics,
Copied contents to your clipboard!